Biotech · Private company
Ascendis Pharma Endocrinology Division A/S
Track this companyFree. Adds Ascendis Pharma Endocrinology Division A/S to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- LonapegsomatropinPhase 3 · Adult Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- LonapegsomatropinPhase 3 · Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Once daily subcutaneous injection of GenotropinPhase 3 · Growth Hormone Deficiency, PediatricClinicalTrials.gov · fetched Nov 12, 2026
- Once weekly subcutaneous injection of TransCon hGHPhase 3 · Growth Hormone Deficiency, PediatricClinicalTrials.gov · fetched Nov 12, 2026
- SomatropinPhase 3 · Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- TransCon hGHPhase 3 · Growth Hormone Deficiency, PediatricClinicalTrials.gov · fetched Nov 12, 2026
- LonapegsomatropinPhase 2 · Turner SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SomatropinPhase 2 · Turner SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- No interventionGrowth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFARECRUITING · started Mar 20, 2023ClinicalTrials.gov NCT05820672 · fetched Nov 12, 2026
- A Post-Authorisation Safety Study (PASS) of Patients Treated With LonapegsomatropinRECRUITING · started Mar 20, 2023ClinicalTrials.gov NCT05775523 · fetched Nov 12, 2026
- A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner SyndromePHASE2 · ACTIVE_NOT_RECRUITING · started Feb 15, 2023ClinicalTrials.gov NCT05690386 · fetched Nov 12, 2026
- A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone DeficiencyPHASE3 · COMPLETED · started Dec 16, 2021ClinicalTrials.gov NCT05171855 · fetched Nov 12, 2026
- A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone DeficiencyPHASE3 · COMPLETED · started Dec 3, 2020ClinicalTrials.gov NCT04615273 · fetched Nov 12, 2026
- A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone DeficiencyPHASE3 · COMPLETED · started Nov 13, 2017ClinicalTrials.gov NCT03305016 · fetched Nov 12, 2026
- A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)PHASE3 · COMPLETED · started Dec 13, 2016ClinicalTrials.gov NCT02781727 · fetched Nov 12, 2026